Pharmaceutical and Medicinal Chemistry Final Year Project Topics & Materials PDF

List of Best Pharmaceutical and Medicinal Chemistry Project Topics & their Complete (PDF, DOC) Materials for Students

No downloadable project topics were found under this field. Below is a list of project topics that you can consider.

Recent Pharmaceutical and Medicinal Chemistry Project Topics & Research Material Areas for Final Year & Undergraduate Students (in Nigeria & Other Countries)

  • Drug Discovery Techniques: Explore advanced methods and technologies utilized in drug discovery, such as high-throughput screening, virtual screening, combinatorial chemistry, and fragment-based drug design.
  • Target Identification and Validation: Investigate strategies for identifying and validating potential drug targets, including the use of genomics, proteomics, and computational biology to understand disease mechanisms and select promising molecular targets.
  • Structure-Activity Relationship (SAR) Studies: Conduct SAR studies to elucidate the relationship between the chemical structure of a drug molecule and its pharmacological activity, aiming to optimize potency, selectivity, and pharmacokinetic properties.
  • Natural Products as Drug Leads: Investigate natural products sourced from plants, animals, and microorganisms as potential leads for drug development, including isolation, structural elucidation, and pharmacological evaluation.
  • Medicinal Chemistry of Anticancer Agents: Explore the design, synthesis, and evaluation of novel anticancer agents targeting various mechanisms, such as DNA damage, cell cycle regulation, angiogenesis, and apoptosis.
  • Antibacterial and Antifungal Agents: Investigate the medicinal chemistry of antibiotics and antifungal agents, including the design of new scaffolds, mechanisms of action, resistance mechanisms, and strategies to overcome resistance.
  • Neuropharmacology and CNS Drugs: Study the medicinal chemistry of drugs targeting the central nervous system (CNS), including neurotransmitter systems, ion channels, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
  • Cardiovascular Drug Discovery: Explore the design and development of drugs for the treatment of cardiovascular diseases, including hypertension, dyslipidemia, thrombosis, and heart failure.
  • Anti-Inflammatory and Immunomodulatory Agents: Investigate the design and synthesis of anti-inflammatory and immunomodulatory drugs targeting pathways involved in inflammation, autoimmune diseases, and allergic reactions.
  • Pain Management: Study the medicinal chemistry of analgesic drugs, including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and novel targets for pain relief with improved efficacy and reduced side effects.
  • Drug Delivery Systems: Investigate innovative drug delivery systems, including nanoparticles, liposomes, micelles, and implants, for improving the pharmacokinetics, bioavailability, and targeting of therapeutic agents.
  • Pharmacogenomics and Personalized Medicine: Explore the role of pharmacogenomics in tailoring drug therapy to individual patients based on their genetic makeup, including the design of drugs with improved efficacy and safety profiles.
  • Bioconjugation Chemistry: Study the synthesis and applications of bioconjugates, such as antibody-drug conjugates (ADCs), peptide-drug conjugates, and nucleic acid-drug conjugates, for targeted drug delivery and imaging.
  • Fragment-Based Drug Discovery (FBDD): Investigate FBDD approaches for identifying small molecule fragments that bind to target proteins, followed by fragment elaboration and optimization into lead compounds.
  • Pharmacokinetics and Drug Metabolism: Explore the principles of pharmacokinetics and drug metabolism, including absorption, distribution, metabolism, excretion (ADME), and the role of drug metabolism in drug-drug interactions and toxicity.
  • Protein-Protein Interactions: Study the medicinal chemistry of disrupting or modulating protein-protein interactions implicated in disease pathways, including the design of small molecules, peptides, and peptidomimetics.
  • Epigenetic Modulators: Investigate the design and synthesis of small molecules targeting epigenetic enzymes, such as histone deacetylases (HDACs) and DNA methyltransferases (DNMTs), for the treatment of cancer and other diseases.
  • GPCR Ligands: Study the medicinal chemistry of G protein-coupled receptors (GPCRs), a major class of drug targets, including the design of ligands with improved selectivity, potency, and pharmacokinetic properties.
  • Ion Channel Modulators: Investigate the design and synthesis of ion channel modulators for the treatment of neurological disorders, cardiac arrhythmias, and other diseases associated with ion channel dysfunction.
  • Anti-Viral Agents: Explore the medicinal chemistry of antiviral drugs targeting viral enzymes, replication processes, and host cell interactions, including the design of inhibitors for HIV, hepatitis, influenza, and emerging viral infections.
  • Anti-Parasitic Drugs: Study the design and development of drugs for the treatment of parasitic diseases, including malaria, trypanosomiasis, leishmaniasis, and helminth infections, with a focus on novel targets and mechanisms of action.
  • Immunotherapy Agents: Investigate the medicinal chemistry of immunotherapy agents, including monoclonal antibodies, immune checkpoint inhibitors, and cytokine modulators, for the treatment of cancer and autoimmune diseases.
  • RNA Targeting Therapeutics: Explore the design and synthesis of small molecules, antisense oligonucleotides, and RNA interference (RNAi) agents targeting RNA molecules involved in disease processes, such as microRNAs and mRNA.
  • Protein Degradation: Study the medicinal chemistry of small molecules targeting protein degradation pathways, such as proteasomal and lysosomal degradation, for the treatment of cancer and neurodegenerative diseases.
  • Antibody Therapeutics: Investigate the design and engineering of therapeutic antibodies for the treatment of cancer, autoimmune diseases, and infectious diseases, including the optimization of antibody affinity, specificity, and pharmacokinetics.
  • Metabolic Syndrome Therapies: Explore the design of drugs targeting metabolic pathways involved in obesity, type 2 diabetes, dyslipidemia, and cardiovascular diseases, with a focus on multi-targeted approaches and combination therapies.
  • Stem Cell Therapies: Study the medicinal chemistry of small molecules and biologics for modulating stem cell fate and function, including the design of molecules promoting stem cell proliferation, differentiation, and homing.
  • Nanomedicine: Investigate the applications of nanotechnology in drug delivery, imaging, and therapy, including the design of nanoparticle-based formulations for targeted delivery of therapeutic agents to specific tissues or cells.
  • Radiopharmaceuticals: Study the medicinal chemistry of radiopharmaceuticals for imaging and therapy, including the design of radiotracers for positron emission tomography (PET), single-photon emission computed tomography (SPECT), and targeted radionuclide therapy.
  • Drug Repurposing: Explore the repurposing of existing drugs for new therapeutic indications, including computational approaches for drug repurposing, identification of new targets, and clinical evaluation of repurposed drugs.
  • Green Chemistry in Medicinal Chemistry: Investigate sustainable and environmentally friendly approaches to drug synthesis and development, including the use of renewable resources, catalytic reactions, and solvent-free processes.
  • Fragment-Based Lead Optimization: Study strategies for optimizing fragment hits into lead compounds, including structure-guided design, fragment linking, and scaffold hopping approaches, to improve potency, selectivity, and pharmacokinetic properties.
  • Pharmacology of Biologics: Explore the pharmacology of biologic drugs, including monoclonal antibodies, recombinant proteins, and gene therapies, focusing on mechanisms of action, pharmacokinetics, and immunogenicity.
  • Personalized Cancer Therapies: Investigate personalized approaches to cancer therapy, including the use of genomic profiling, biomarker-driven therapy selection, and combination therapies tailored to individual patients’ genetic and molecular profiles.
  • Drug-Drug Interactions: Study the mechanisms and consequences of drug-drug interactions, including pharmacokinetic interactions mediated by drug metabolizing enzymes and transporters, and their implications for drug safety and efficacy.
  • Chemoenzymatic Synthesis: Explore the integration of enzymatic and chemical synthesis approaches for the efficient production of complex drug molecules, including the use of biocatalysts and engineered enzymes.
  • Computational Medicinal Chemistry: Investigate computational methods and tools for drug design, including molecular modeling, molecular dynamics simulations, virtual screening, and machine learning approaches for predicting ligand binding and ADMET properties.
  • Biomaterials for Drug Delivery: Study the design and characterization of biomaterials for drug delivery applications, including hydrogels, nanoparticles, and scaffolds for controlled release and tissue engineering.
  • Regenerative Medicine Therapies: Investigate the development of small molecules, biologics, and biomaterials for regenerative medicine applications, including stem cell therapies, tissue engineering, and organ transplantation.
  • Drug Safety and Toxicology: Explore the principles of drug safety assessment and toxicology, including the prediction, detection, and mitigation of adverse effects associated with drug therapy, using in vitro, in vivo, and computational methods.

Top Final Year Project Project Topics for Pharmaceutical and Medicinal Chemistry Students & Researchers

  1. Design and synthesis of novel anti-cancer agents
  2. Development of new antibiotics to combat drug-resistant bacteria
  3. Structure-activity relationship studies on anti-inflammatory compounds
  4. Targeting epigenetic modifications in cancer therapy
  5. Design of selective kinase inhibitors for cancer treatment
  6. Discovery of novel anti-viral agents
  7. Development of anti-parasitic drugs
  8. Design and synthesis of multi-targeted drugs for complex diseases
  9. Investigation of natural products for anti-diabetic properties
  10. Design and optimization of anti-Alzheimer’s drugs
  11. Development of personalized medicine in oncology
  12. Synthesis of bioconjugates for targeted drug delivery
  13. Investigation of metal-based drugs for cancer therapy
  14. Design and synthesis of anti-tuberculosis agents
  15. Development of anti-fungal drugs
  16. Exploration of plant-derived compounds for cardiovascular diseases
  17. Design and optimization of anti-inflammatory peptides
  18. Development of neuroprotective agents for neurodegenerative disorders
  19. Drug repurposing strategies for existing drugs in new indications
  20. Synthesis of radiolabeled compounds for imaging studies
  21. Discovery of novel analgesics for pain management
  22. Development of anti-malarial drugs
  23. Investigation of anti-aging compounds in medicinal chemistry
  24. Design and synthesis of anti-angiogenic agents for cancer therapy
  25. Development of drugs targeting ion channels in the central nervous system
  26. Structure-based drug design for G protein-coupled receptors
  27. Design of prodrugs for improved drug delivery
  28. Development of new anti-psychotic medications
  29. Synthesis of anti-obesity drugs
  30. Design and optimization of anti-viral vaccines
  31. Investigation of nanomedicine in drug delivery
  32. Development of anti-hypertensive agents
  33. Design of anti-microbial peptides
  34. Discovery of new targets for anti-cancer therapy
  35. Development of anti-viral drugs for emerging diseases
  36. Investigation of pharmacogenomics in drug development
  37. Design and synthesis of anti-angiogenic agents for ophthalmic disorders
  38. Development of anti-inflammatory agents for autoimmune diseases
  39. Synthesis of anti-coagulant drugs
  40. Exploration of marine natural products for drug discovery
  41. Design and optimization of anti-epileptic drugs
  42. Development of anti-viral agents for respiratory infections
  43. Investigation of anti-fibrotic drugs
  44. Synthesis of novel antibiotics for Gram-negative bacteria
  45. Design and optimization of anti-cancer immunotherapies
  46. Development of anti-viral agents for RNA viruses
  47. Exploration of medicinal plants for wound healing properties
  48. Design of anti-inflammatory drugs for gastrointestinal disorders
  49. Discovery of novel anti-hypertensive agents
  50. Synthesis of anti-trypanosomal drugs
  51. Development of anti-viral agents for herpes viruses
  52. Investigation of anti-cancer drug resistance mechanisms
  53. Design and synthesis of anti-arrhythmic drugs
  54. Development of anti-viral agents for influenza
  55. Exploration of drug-drug interactions in pharmacotherapy
  56. Design of anti-microbial coatings for medical devices
  57. Discovery of novel anti-fungal agents
  58. Synthesis of anti-leishmanial drugs
  59. Development of anti-cancer drugs targeting DNA repair mechanisms
  60. Investigation of anti-inflammatory agents for respiratory diseases
  61. Design and optimization of anti-migraine drugs
  62. Development of anti-viral agents for retroviruses
  63. Exploration of natural products for anti-microbial activity
  64. Synthesis of anti-tryptophan drugs for psychiatric disorders
  65. Design of anti-viral agents for hepatitis viruses
  66. Discovery of novel anti-cancer drug delivery systems
  67. Development of anti-oxidant drugs for neuroprotection
  68. Investigation of anti-viral agents for dengue fever
  69. Design and synthesis of anti-coagulant peptides
  70. Exploration of medicinal plants for anti-diarrheal properties
  71. Development of anti-inflammatory agents for rheumatoid arthritis
  72. Synthesis of anti-leukemic drugs
  73. Design of anti-viral agents for Zika virus
  74. Discovery of novel anti-tubercular agents
  75. Investigation of anti-microbial peptides for skin infections
  76. Development of anti-cancer drugs targeting metabolism
  77. Exploration of natural products for anti-inflammatory properties
  78. Synthesis of anti-trypanosomal peptides
  79. Design and optimization of anti-diabetic drugs
  80. Development of anti-viral agents for norovirus
  81. Investigation of anti-fungal peptides
  82. Design of anti-viral agents for respiratory syncytial virus
  83. Discovery of novel anti-cancer drugs targeting the cell cycle
  84. Synthesis of anti-malarial peptides
  85. Development of anti-inflammatory agents for inflammatory bowel diseases
  86. Exploration of drug delivery systems for ocular diseases
  87. Design and optimization of anti-coagulant peptides
  88. Development of anti-viral agents for coronaviruses
  89. Investigation of anti-cancer drugs targeting the immune system
  90. Synthesis of anti-leukemic peptides
  91. Design of anti-microbial agents for veterinary medicine
  92. Discovery of novel anti-cancer drugs targeting apoptosis
  93. Development of anti-inflammatory agents for skin disorders
  94. Exploration of natural products for anti-viral properties
  95. Synthesis of anti-malarial peptides
  96. Design and optimization of anti-diabetic peptides
  97. Development of anti-viral agents for hepatitis B virus
  98. Investigation of anti-bacterial peptides for wound healing
  99. Design of anti-viral agents for yellow fever
  100. Discovery of novel anti-cancer drugs targeting angiogenesis
  101. Synthesis of anti-leukemic peptides
  102. Development of anti-inflammatory agents for psoriasis
  103. Exploration of drug delivery systems for brain disorders
  104. Design and optimization of anti-coagulant peptides
  105. Development of anti-viral agents for enteroviruses
  106. Investigation of anti-cancer drugs targeting DNA damage repair
  107. Synthesis of anti-malarial peptides
  108. Design and optimization of anti-diabetic peptides
  109. Development of anti-viral agents for hepatitis C virus
  110. Exploration of natural products for anti-microbial properties
  111. Discovery of novel anti-cancer drugs targeting the PI3K/AKT pathway
  112. Synthesis of anti-leukemic peptides
  113. Design of anti-inflammatory agents for atopic dermatitis
  114. Development of anti-viral agents for herpes simplex virus
  115. Investigation of anti-bacterial peptides for oral health
  116. Design and optimization of anti-coagulant peptides
  117. Exploration of drug delivery systems for cancer immunotherapy
  118. Discovery of novel anti-fungal drugs
  119. Synthesis of anti-malarial peptides
  120. Development of anti-viral agents for influenza A virus
  121. Investigation of anti-cancer drugs targeting the Wnt/β-catenin pathway
  122. Design and optimization of anti-diabetic peptides
  123. Development of anti-inflammatory agents for osteoarthritis
  124. Exploration of natural products for anti-parasitic properties
  125. Synthesis of anti-leukemic peptides
  126. Design of anti-viral agents for respiratory viruses
  127. Discovery of novel anti-cancer drugs targeting the MAPK pathway
  128. Development of anti-viral agents for picornaviruses
  129. Investigation of anti-microbial peptides for food preservation
  130. Design and optimization of anti-coagulant peptides
  131. Exploration of drug delivery systems for gene therapy
  132. Synthesis of anti-malarial peptides
  133. Development of anti-inflammatory agents for systemic lupus erythematosus
  134. Design of anti-viral agents for adenoviruses
  135. Discovery of novel anti-cancer drugs targeting autophagy
  136. Investigation of anti-bacterial peptides for veterinary medicine
  137. Design and optimization of anti-diabetic peptides
  138. Development of anti-viral agents for flaviviruses
  139. Exploration of natural products for anti-inflammatory properties
  140. Synthesis of anti-leukemic peptides
  141. Design and optimization of anti-coagulant peptides
  142. Development of anti-inflammatory agents for allergic diseases
  143. Exploration of drug delivery systems for cardiovascular diseases
  144. Discovery of novel anti-fungal peptides
  145. Synthesis of anti-malarial peptides
  146. Development of anti-viral agents for hepatitis E virus
  147. Investigation of anti-cancer drugs targeting the Hedgehog pathway
  148. Design and optimization of anti-diabetic peptides
  149. Development of anti-inflammatory agents for inflammatory lung diseases
  150. Exploration of natural products for anti-viral properties
  151. Synthesis of anti-leukemic peptides
  152. Design of anti-microbial agents for water treatment
  153. Development of anti-viral agents for enteric viruses
  154. Investigation of anti-bacterial peptides for agricultural applications
  155. Design and optimization of anti-coagulant peptides
  156. Exploration of drug delivery systems for ocular infections
  157. Discovery of novel anti-cancer drugs targeting the Notch pathway
  158. Synthesis of anti-malarial peptides
  159. Development of anti-inflammatory agents for neuroinflammatory disorders
  160. Design of anti-viral agents for alphaviruses
  161. Investigation of anti-cancer drugs targeting the JAK/STAT pathway
  162. Design and optimization of anti-diabetic peptides
  163. Development of anti-viral agents for paramyxoviruses
  164. Exploration of natural products for anti-malarial properties
  165. Synthesis of anti-leukemic peptides
  166. Development of anti-inflammatory agents for cardiovascular diseases
  167. Design of anti-microbial peptides for water purification
  168. Discovery of novel anti-cancer drugs targeting the TGF-β pathway
  169. Exploration of drug delivery systems for gastrointestinal disorders
  170. Design and optimization of anti-coagulant peptides
  171. Synthesis of anti-malarial peptides
  172. Development of anti-viral agents for rotaviruses
  173. Investigation of anti-bacterial peptides for skin infections
  174. Design and optimization of anti-diabetic peptides
  175. Discovery of novel anti-fungal peptides
  176. Synthesis of anti-leukemic peptides
  177. Development of anti-inflammatory agents for atopic dermatitis
  178. Design of anti-viral agents for emerging infectious diseases